Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 12, 2026, 3:44 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1417–1440 of 12,661 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Period A Clear all

Conditions: Traumatic Brain Injury
Interventions: aerosolized 2% lidocaine (20mg/ml), instilled 0.9% sodium chloride (NS), instilled 2% lidocaine solution, Endotracheal Suctioning (ETS); Drug · Procedure
Lead sponsor: The University of Texas Health Science Center, Houston; Other
Eligibility: Up to 16 Years
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2025
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Cirrhosis, Ascites, Liver Diseases, Frailty, Sarcopenia, Hepatic Encephalopathy
Interventions: Medically-tailored meals (MTM), Protein supplements, Nutrition education handout; Other · Dietary Supplement · Behavioral
Lead sponsor: University of Michigan; Other
Eligibility: 18 Years and older
Enrollment: 17 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2023
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Postoperative Pain, Objective Assessment of Sedation
Interventions: Anesthesia Premedication, Induction and Maintenance, Pupillometry after administration of anesthetic drugs; Drug · Procedure
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years to 99 Years
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2016
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Atrial Fibrillation, Afib, ECG
Interventions: ECG co-measurement; Device
Lead sponsor: TriVirum, Inc.; Industry
Eligibility: 18 Years to 90 Years
Enrollment: 15 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023
U.S. locations: 1
States / cities: San Diego, California

Conditions: Invasive Aspergillosis
Interventions: Olorofim, AmBisome®; Drug
Lead sponsor: F2G Ltd; Industry
Eligibility: 18 Years and older
Enrollment: 225 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2026
U.S. locations: 24
States / cities: Birmingham, Alabama • Duarte, California • Sacramento, California + 21 more

Conditions: Chronic Fatigue, Breast Cancer, Sleepiness
Interventions: Relaxation Acupressure, Stimulating Acupressure; Behavioral
Lead sponsor: University of Michigan; Other
Eligibility: 18 Years and older · Female only
Enrollment: 288 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2014
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Presbyopia
Interventions: VisAbility™ Micro Insert; Device
Lead sponsor: VisDura, Inc.; Industry
Eligibility: 45 Years to 60 Years
Enrollment: 287 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2021
U.S. locations: 13
States / cities: Orange, California • San Diego, California • Honolulu, Hawaii + 10 more

Conditions: Generalized Anxiety Disorder (GAD), Anxiety Disorders
Interventions: Low-Dose Cannabidiol, Placebo Matched to Moderate-Dose Cannabidiol, Moderate-Dose Cannabidiol, Placebo Matched to Low-Dose Cannabidiol; Drug
Lead sponsor: Wayne State University; Other
Eligibility: 18 Years to 45 Years
Enrollment: 90 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Detroit, Michigan

Conditions: IDH1 Mutation, Acute Myeloid Leukemia (AML), Hematopoietic Stem Cell Transplant (HSCT)
Interventions: Ivosidenib, Placebo; Drug
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years to 75 Years
Enrollment: 75 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2030
U.S. locations: 7
States / cities: Atlanta, Georgia • Kansas City, Kansas • Boston, Massachusetts + 3 more

Conditions: Postpartum Depression
Interventions: Web-based CBT for PPD; Behavioral
Lead sponsor: Oregon Research Institute; Other
Eligibility: 18 Years and older · Female only
Enrollment: 53 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2013
U.S. locations: 2
States / cities: Iowa City, Iowa • Eugene, Oregon

Conditions: Solid Tumor, Adult
Interventions: FCN-437; Drug
Lead sponsor: Fochon Pharmaceuticals, Ltd.; Industry
Eligibility: 18 Years and older
Enrollment: 22 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2021
U.S. locations: 3
States / cities: Duarte, California • Nashville, Tennessee • San Antonio, Texas

Conditions: Invasive Breast Cancer (Stage I-III), Ductal Carcinoma in Situ, Lobular Carcinoma in Situ, Lobular Carcinoma, Fatigue Related to Cancer Treatment
Interventions: Naltrexone, Sugar Pill; Drug
Lead sponsor: Dana-Farber Cancer Institute; Other
Eligibility: 18 Years and older
Enrollment: 3 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2015
U.S. locations: 2
States / cities: Boston, Massachusetts

Conditions: Obesity
Interventions: Intervention; Behavioral
Lead sponsor: Oregon Health and Science University; Other
Eligibility: 21 Years and older
Enrollment: 452 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2017
U.S. locations: 1
States / cities: Portland, Oregon

Conditions: Nicotine Use Disorder, Substance Use Disorders
Interventions: Active TI-NDBS, Sham TI-NDBS, tDCS; Device · Other
Lead sponsor: Indiana University; Other
Eligibility: 18 Years to 50 Years
Enrollment: 10 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2022
U.S. locations: 1
States / cities: Bloomington, Indiana

Conditions: Diabetes, Insulin Resistance, Obesity, Bariatric Surgery Candidate, Roux-en-y Gastric Bypass, Liver Diseases
Interventions: Endoscopy biopsy, Surgical biopsy, Mixed-meal tolerance test, Excised Liver Tissue Sampling; Other
Lead sponsor: Vanderbilt University Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 500 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2028
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Stroke, Aphasia
Interventions: transcranial direct current stimulation; Device
Lead sponsor: Northwell Health; Other
Eligibility: 18 Years and older
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2017
U.S. locations: 1
States / cities: Manhasset, New York

Conditions: Resistance Training, Yoga
Interventions: Yoga, High-speed Resistance Training; Other
Lead sponsor: University of Miami; Other
Eligibility: 30 Years to 80 Years
Enrollment: 35 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022
U.S. locations: 1
States / cities: Coral Gables, Florida

Conditions: Lennox-Gastaut Syndrome (LGS)
Interventions: Placebo, Perampanel; Drug
Lead sponsor: Eisai Inc.; Industry
Eligibility: 2 Years and older
Enrollment: 101 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2021
U.S. locations: 31
States / cities: Little Rock, Arkansas • Palo Alto, California • Gulf Breeze, Florida + 25 more

Conditions: Subarachnoid Hemorrhage, Stroke
Interventions: IV acetaminophen, Oral acetaminophen, Oral placebo, IV placebo; Drug
Lead sponsor: Milton S. Hershey Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 3 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: Hershey, Pennsylvania

Conditions: Inflammatory Bowel Disease (IBD)
Interventions: Gut Microbial Transplantation; Drug
Lead sponsor: Corewell Health West; Other
Eligibility: 7 Years to 21 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2013
U.S. locations: 1
States / cities: Grand Rapids, Michigan

Conditions: Type 2 Diabetes Mellitus
Interventions: Saxagliptin, Dapagliflozin; Drug
Lead sponsor: AstraZeneca; Industry
Eligibility: 18 Years to 45 Years
Enrollment: 42 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012
U.S. locations: 1
States / cities: Omaha, Nebraska

Conditions: Sickle Cell Disease
Interventions: Propranolol, Placebo; Drug
Lead sponsor: Laura M. De Castro, MD; Other
Eligibility: 18 Years and older
Enrollment: 31 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2013
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Intermittent Claudication
Interventions: Trans sodium crocetinate (TSC), 0.9% normal saline; Drug
Lead sponsor: Diffusion Pharmaceuticals Inc; Industry
Eligibility: 40 Years and older
Enrollment: 48 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2010
U.S. locations: 7
States / cities: Birmingham, Alabama • Santa Rosa, California • Stanford, California + 4 more

Conditions: Narcolepsy
Interventions: E2086, Placebo; Drug
Lead sponsor: Eisai Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 64 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 17
States / cities: Santa Ana, California • Brandon, Florida • Medley, Florida + 12 more

Search by objective public record fields.

Aerosolized Endotracheal Lidocaine to Avoid Intracranial Pressure Spikes in Patients With Severe Traumatic Brain Injury

The BRAINFOOD Trial to Prevent Recurrent Hepatic Encephalopathy.

Infrared Pupillometry During General Anesthesia to Predict Pain

Clinical Performance of AFGen1

Olorofim Aspergillus Infection Study

Acupressure for Persistent Cancer Related Fatigue

Long Term Follow-up of the VisAbility™ Micro Insert System for Presbyopic Patients

Cannabidiol-Assisted Learning for Managing Generalized Anxiety Disorder

Ivosidenib as Post-HSCT Maintenance for AML

Cognitive Behavioral Therapy Delivered Over the Internet for Women With Postpartum Depression

Study of FCN-437c in Patients With Advanced Solid Tumors

Naltrexone RCT for Treatment-Emergent Fatigue in Patients Receiving Radiation Therapy for Breast Cancer

Evaluation of Safety and Health Involvement For Truck Drivers

Temporal Interference Neurostimulation and Addiction

Physiologic and Functional Adaptations of Insulin Sensitive Tissues

Evaluating Anodal tDCS Preceding Aphasia Therapy

Mindfulness and Yoga or Resistance Exercise Training Fpr Parkinson's Patients

Study of Perampanel as Adjunctive Treatment for Inadequately Controlled Seizures Associated With Lennox-Gastaut Syndrome

Clinical, Pharmacological and Molecular Effects of IV and Oral Acetaminophen in Adults With aSAH

Gut Microbial Transplantation in Pediatric Inflammatory Bowel Diseases

Drug Interaction Study of Saxagliptin in Combination With Dapagliflozin in Healthy Participants

Study of Propranolol as Anti-Adhesive Therapy in Sickle Cell Disease (SCD)

Safety, Efficacy, and Pharmacokinetics (PK) Study of Trans Sodium Crocetinate (TSC) in Patients With Intermittent Claudication

A Study to Evaluate the Efficacy and Safety of E2086 in Adults With Narcolepsy